NEW YORK, March 20, 2017 (GLOBE NEWSWIRE) -- Golden Star Enterprises Ltd. (OTCPK:GSPT) reports that the Company has signed an Agreement with Dantas Enterprises Ltd. to buy its business known as WeeCare Wholesale Ltd. and all the assets thereof.
WeeCare Wholesale Limited is working to develop an online and offline warehouse that would provide a wide selection of legal cannabis products and accessories. The company will uniquely position itself to offer independent wholesale distribution, marketing and sales promotion of legal cannabis throughout North America where legalized. The company will take advantage of economies of scale by sourcing legal cannabis products and accessories in bulk directly from producers, cultivators and manufacturers and sell directly to the target customers using B2B and B2C methods. WeeCare Wholesale Limited will support the legal retailers with the need of one stop shop for various brands of legal cannabis products and accessories.
The Agreement calls for issuance of cash and restricted shares of Golden Star Enterprises Ltd. to complete the acquisition. We will continue our communication with shareholders in the coming weeks and months on our efforts and the potential impact of this acquisition for the Company.
Robert Klein, President of Golden Star states, “The decision for Golden Star to enter into this Agreement was made with the knowledge that the legal marijuana industry is still evolving. The WeeCare Wholesale Ltd. plan is a model that could turn something that’s so unorganized without structure into something efficient, something that is fast, easy, safe and as hassle free as possible, something where target customers can obtain legal cannabis products and accessories smoothly and efficiently.”
/s/ Robert Klein
Robert Klein, President
For further information contact: 1-888-488-6882
Visit our website at www.goldenstarent.com
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein which are not historical fact are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays in testing and evaluation of products and other risks detailed from time to time in Golden Star’s filings with the OTC Markets.